BNB PLUS CORP (BNBX) Stock Price & Overview
NASDAQ:BNBX • US03815U6073
Current stock price
The current stock price of BNBX is 0.6565 USD. Today BNBX is up by 0.58%. In the past month the price decreased by -11.13%.
BNBX Key Statistics
- Market Cap
- 3.578M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -272.19
- Dividend Yield
- N/A
BNBX Stock Performance
BNBX Stock Chart
BNBX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to BNBX.
BNBX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BNBX. The financial health of BNBX is average, but there are quite some concerns on its profitability.
BNBX Earnings
BNBX Forecast & Estimates
For the next year, analysts expect an EPS growth of 77.08% and a revenue growth 40% for BNBX
BNBX Groups
Sector & Classification
BNBX Financial Highlights
Over the last trailing twelve months BNBX reported a non-GAAP Earnings per Share(EPS) of -272.19. The EPS increased by 92.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -340.95% | ||
| ROE | -374.65% | ||
| Debt/Equity | 0 |
BNBX Ownership
BNBX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.82 | 182.568B | ||
| DHR | DANAHER CORP | 22.51 | 135.149B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 134.21 | 44.15B | ||
| A | AGILENT TECHNOLOGIES INC | 17.26 | 32.635B | ||
| WAT | WATERS CORP | 20.94 | 29.846B | ||
| IQV | IQVIA HOLDINGS INC | 13.52 | 29.085B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.86 | 25.615B | ||
| ILMN | ILLUMINA INC | 24.35 | 19.476B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.45 | 18.366B | ||
| MEDP | MEDPACE HOLDINGS INC | 28.59 | 14.143B | ||
| RVTY | REVVITY INC | 16.13 | 9.943B | ||
| CRL | CHARLES RIVER LABORATORIES | 15.59 | 8.561B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 8.472B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BNBX
Company Profile
BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 26 full-time employees. The company went IPO on 2001-08-24. Its segments include digital asset treasury, therapeutic deoxyribonucleic acid (DNA) production services, DNA tagging and security products and services. Its digital asset treasury segment is engaged in managing digital assets. Its therapeutic DNA production services segment is engaged in nucleic-acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP and LineaIVT. Its DNA tagging and security products and services segment is engaged in the manufacture and detection of DNA for industrial supply chains and security services. Its subsidiary LineaRx, Inc., is engaged in commercializing nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
Company Info
IPO: 2001-08-24
BNB PLUS CORP
50 Health Sciences Drive
Stony Brook NEW YORK US
Employees: 26
Phone: 18009279800
BNB PLUS CORP / BNBX FAQ
Can you describe the business of BNB PLUS CORP?
BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 26 full-time employees. The company went IPO on 2001-08-24. Its segments include digital asset treasury, therapeutic deoxyribonucleic acid (DNA) production services, DNA tagging and security products and services. Its digital asset treasury segment is engaged in managing digital assets. Its therapeutic DNA production services segment is engaged in nucleic-acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP and LineaIVT. Its DNA tagging and security products and services segment is engaged in the manufacture and detection of DNA for industrial supply chains and security services. Its subsidiary LineaRx, Inc., is engaged in commercializing nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
What is the current price of BNBX stock?
The current stock price of BNBX is 0.6565 USD. The price increased by 0.58% in the last trading session.
What is the dividend status of BNB PLUS CORP?
BNBX does not pay a dividend.
What is the ChartMill rating of BNB PLUS CORP stock?
BNBX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Would investing in BNB PLUS CORP be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BNBX.
What is the employee count for BNBX stock?
BNB PLUS CORP (BNBX) currently has 26 employees.